09/03/2026
Dravet syndrome is one of the most severe forms of childhood epilepsy. Seizures begin in
infancy, resist most treatments, and can be life-threatening. Parents have had very few options.
Now an experimental drug called zorevunersen is showing extraordinary results. In clinical trials,
it reduced seizures by up to 91% while also improving quality of life for many of the children.
The drug works by targeting the underlying genetic cause of the condition, not just managing
symptoms.
For families who have spent years watching their children suffer through dozens of seizures a
day, this could be genuinely life-changing.
Source: ScienceDaily, March 2026
Shared for informational purposes only. Consult a medical professional for health advice.
